Medical Device Investing Orchestra BioMed Presents New AVIM Therapy Clinical Data at HRX Demonstrating Substantial and Sustained Blood Pressure Reductions that are Reproducible Upon Reactivation Following Washout
Medical Device Investing Study of Medtronic Hugo robotic-assisted surgery system in hernia repair meets safety and effectiveness endpoints
Medical Device Investing FDA Clears MiniMed 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes
Medical Device Investing Orchestra BioMed Announces Publication of Clinical Data Demonstrating Favorable Blood Pressure and Hemodynamic Effects of AVIM Therapy in JACC: Clinical Electrophysiology
Medical Device Investing Medtronic announces Board appointments and shareholder value creation initiatives to advance strategic priorities
Medical Device Investing Medtronic to announce financial results for its first quarter of fiscal year 2026
Medical Device Investing Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed
Medical Device Investing Medtronic secures CE Mark for MiniMed 780G System for insulin-requiring people with diabetes including expanded indications in children as young as two, during pregnancy, and for type 2 diabetes
Medical Device Investing Medtronic announces appointment of MiniMed chief financial officer ahead of intended separation into standalone company
Medical Device Investing Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities
CORRECTED: CHARBONE Hydrogen is Acquiring Hydrogen Production Assets and Closing a First Tranche of $1M Private Placement Financing
CORRIGE: CHARBONE Hydrogene acquiert des actifs de production d'hydrogene et cloture une premiere tranche d'un financement par placement prive de 1 M$
